Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,181 | N/A | 13,250 | 8,151 | 16,723 |
| Other current assets | 817 | 0 | 565 | 3,201 | 2,711 |
| TOTAL | $7,997 | $N/A | $13,815 | $11,352 | $19,433 |
| Non-Current Assets | |||||
| Intangibles | 16 | 0 | 0 | 0 | 21 |
| Other Non-Current Assets | 0 | 0 | 17 | 19 | 0 |
| TOTAL | $16 | $N/A | $17 | $19 | $21 |
| Total Assets | $8,013 | $N/A | $13,832 | $11,371 | $19,455 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,031 | 0 | 947 | 1,635 | 3,076 |
| Accrued Expenses | 2,402 | N/A | 3,148 | 1,411 | 2,448 |
| Other current liabilities | 1,705 | N/A | 7,946 | N/A | N/A |
| TOTAL | $5,137 | $N/A | $12,041 | $3,045 | $5,524 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 94 | 0 | 0 | 0 | 0 |
| TOTAL | $94 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,232 | $N/A | $12,041 | $3,045 | $5,524 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 3,722 | N/A | N/A |
| Common Shares | 1,012 | N/A | 745 | 594 | 594 |
| Retained earnings | -220,452 | N/A | -217,453 | -210,561 | -204,881 |
| Other shareholders' equity | 51,368 | 0 | 51,423 | 51,572 | 51,620 |
| TOTAL | $2,782 | $N/A | $1,791 | $8,326 | $13,931 |
| Total Liabilities And Equity | $8,013 | $0 | $13,832 | $11,371 | $19,455 |